Why the study?
Does the presence of fragmented QRS on ECG predict all-cause or arrhythmic mortality in primary prevention patients with left ventricular dysfunction eligible for ICD therapy?
Does the presence of fragmented QRS on ECG predict all-cause or arrhythmic mortality in primary prevention patients with left ventricular dysfunction eligible for ICD therapy?
The presence of fragmented QRS on ECG does not predict all-cause or arrhythmic mortality in primary prevention patients with left ventricular dysfunction, suggesting it is not a useful marker for ICD risk stratification in this population.
Answers are grounded in this paper and cite their sources.
Does not support fQRS for ICD risk stratification in LV dysfunction; leaves open its prognostic value in other cohorts.
BACKGROUND: Fragmented QRS (fQRS) has been shown to predict cardiac events in select patient populations. Whether fQRS improves patient selection for primary prevention patients eligible for implantable cardioverter-defibrillator (ICD) therapy remains unknown. METHODS AND RESULTS: In a prospective, multisite cohort of 842 patients with left ventricular dysfunction (ejection fraction < or =35%) representing both ischemic and nonischemic etiology, the presence of fQRS on ECG was assessed using standardized criteria. The association between fQRS and all-cause and arrhythmic mortality was evaluated overall and stratified by ICD status using multivariable Cox regression models, adjusted for demographic, clinical, and treatment variables. Fragmented QRS was present in 274 (32.5%) patients, and there were 191 (22.7%) deaths during a mean follow-up of 40+/-17 months. Rates of all-cause mortality did not differ between the fQRS+ (19.7%) and fQRS- (24.1%) groups; adjusted hazard ratio, 0.88; 95% confidence interval, 0.63-1.22; P=0.43. Additionally, rates of arrhythmic mortality were similar between the fQRS+ (9.9%) and fQRS- (12.7%) groups: adjusted hazard ratio, 0.77; 95% confidence interval, 0.49-1.31; P=0.38. Subgroup analyses found no association between fQRS and mortality when the cohort was further stratified by ICD status, etiology of left ventricular dysfunction, wide (>/=120 ms) versus narrow (<120 ms) QRS duration, or fQRS myocardial territory. CONCLUSIONS: In this prospective, multisite cohort of primary prevention patients with left ventricular dysfunction, the presence of fQRS on ECG was not associated with a higher risk of either all-cause or arrhythmic mortality. These findings do not provide evidence that fQRS would be effective in risk stratifying primary prevention patients eligible for ICD therapy.
No takes yet. Share an insight, caveat, or question.
Cheema et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: